✦ LIBER ✦

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

✍ Scribed by P. -A. Löschmann; K. W. Lange; M. Kunow; K. -J. Rettig; P. Jähnig; T. Honoré; L. Turski; H. Wachtel; P. Jenner; C. D. Marsden

Publisher: Springer
Year: 1991
Tongue: English
Weight: 810 KB
Volume: 3
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf02259538

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential interaction of competitive

Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease

✍ Peter-Andreas Löschmann; Ullrich Wüllner; Michael T. Heneka; Jörg B. Schulz; Mar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

1-aminomethyl-5,6-dihydroxy-3-phenylisochroman; NMDA antagonist; CPP; 3-((6)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid

The use of NMDA antagonist memantine in

The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from l-dopa

✍ Hasmet A. Hanaḡasi; Gülüstü Kaptanoǧlu; Hüseyin A. Sahin; Murat Emre 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 1 views

ChemInform Abstract: Two Intermediates i

ChemInform Abstract: Two Intermediates in the Synthesis of Decahydroisoquinolines with NMDA and AMPA Receptor Antagonist Activity.

✍ J. Zukerman-Schpector; Mauricio Vega; I. Caracelli; Luiz C. Dias; Anna M. A. P. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 26 KB 👁 1 views

The α2-adrenergic receptor antagonist id

The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

✍ Brian Henry; Susan H. Fox; David Peggs; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

Comparison between the decrease of dopam

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models

✍ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A

On the role of P2X7receptors in dopamine

On the role of P2X7receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7receptor antagonist A-438079

✍ Daniel Marcellino; Diana Suárez-Boomgaard; María Dolores Sánchez-Reina; José A. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 558 KB